InsidersTradesSigma
Follow the 알지노믹스 share price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares are listed on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 알지노믹스 has recorded 20 public disclosures. Market capitalisation: €753.3bn. The latest transaction was disclosed on 10 July 2026 (Purchase). Among the most active insiders: 이성욱. All data is accessible without an account.
20
Insider Decl.
n/a
Thresholds
n/a
14 ops.
Buy Volume
n/a
4 ops.
Sell Volume
6Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 10 July 2026
Declarations20 total
600,246 sharesKRXDART:20251224000674
20 of 20 declarations
Acerca de 알지노믹스
Algenomics es una empresa que opera en el sector de la salud y farmacéutico, cotizando en el mercado XKRX. Se enfoca en el desarrollo de soluciones innovadoras en el campo de la biotecnología.